European Psychiatry - Volume 33 - March 2016

308 / 812

S304 24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348
Objectives To explore possible subtypes among people with
schizophrenia before discharge by their self-management ability,
self-efficacy and cognitive function status.
Aims To identify possible subtypes among people with
schizophrenia before discharge.
Methods Totally, 150 Chinese people with schizophrenia before
discharged from a tertiary psychiatric hospital in Beijing
were assessed by Self-management Instrument for People with
Schizophrenia and Repeatable Battery for the Assessment of Neu-
ropsychological Status (RBANS). Cluster analysis using SPSS 20.0
packagewas performed to categorize subjects basedon their scores.
Results Four different types of subjects were revealed. Type I low
cognition with no participation (n = 25), patients’ self-management
ability, self-efficacy and cognitive function were very poor; type
II medium cognition with blind confidence (n = 42), patients’ self-
efficacy was good, while self-management ability was poor and
cognitive function is medium; type III high cognition with high
level skill (n = 46), patients’ cognitive function, self-management
ability and self-efficacy were good; type IV low cognition with
medium level skill (n = 37), patients’ cognition was very poor, while
self-management ability and self-efficacyweremedium. These four
types of subjects had significant differences in long-term use of
antipsychotics and primary caregivers’ education level (P < 0.05).
Conclusions The finding of different subtypes of people with
schizophrenia presenting in this sample may help health profes-
sionals give effective screening and targeted discharge measures
which can further promote patients’ recovery and reduce readmis-
sion rates.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW536
Perceived and anticipated stigma in
patients with schizophrenia according
with the length of illness
B. Reneses allego ópez-Micó ∗
A. Fernández del Moral odríguez rgudo
C. Carrascosa , S. Ochoa
1 Hospital Clínico San Carlos, Psiquiatría, Madrid, Spain
2 Hospital Clínico San Carlos, Madrid, Spain
3 Hospital Sant Joan de Déu, Psiquiatría, Barcelona, Spain
∗ Corresponding author.
Introduction Perceived and anticipated stigma are relevant issues
in patients with schizophrenia. Stigma has negative consequences
both in quality of life and in the course of illness.
Objectives To analyze differences in perceived and anticipated
discrimination in two groups of patients with schizophrenia: one
with a recent diagnosis of illness and another with a long course of
disease.
Methods A cross-sectional study was carried out in a sample of
100 patients with diagnosis of schizophrenia, 18 or more years old,
clinically stabilized, without axis I DSM-IV comorbidity. Patients
received treatment in the outpatient services of a catchment area
in Madrid. Perceived and anticipated discrimination was evalu-
ated trough the DISC-12 (Discrimination and Stigma scale). Other
study variables were: socio-demographic status, length of dis-
ease, symptoms of depression (Calgary Scale) and functionality
degree measured by Global Assessment of Function (GAF). Two
sub-groups of patients were compared: one with a length of ill-
ness below 5 years and a second one with a length of illness over
5 years.
Results Patients with a length of illness longer than 5 years
showed elevated degree of perceived and anticipated discrimina-
tion comparedwith patientswith less than 5 years of illness course.
In the same way, patients with a recent diagnosis of illness showed
increased scores in the measure of face the stigma.
Conclusions Preventive strategies to avoid the stigma in
schizophrenia should consider some differences in patients in rela-
tionship with the length of evolution of illness in order to be more
accurate. Early intervention programs about stigma are necessary.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW537
Perceived and anticipating stigma in
schizophrenia in relationship with
depressive symptoms and
functionality degree
C. López-Micó ∗, B. Reneses , L. Gallego , G. Maria Sagrario ,
R. Fernandez , Á. Huidobro , L. Reyes , P. Gómez
Hospital Clínico San Carlos, Psiquiatría, Madrid, Spain
∗ Corresponding author.
Introduction Perceived and anticipated stigma is relevant issues
in patients with schizophrenia. Stigma has negative consequences
both in quality of life and in the course of illness.
Objectives To analyze the degree of perceived and antici-
pated stigma and discrimination in patients with schizophrenia
and their relationship with clinical and socio-demographic
variables.
Methods A cross-sectional study was carried out in a sample of
100 patients with diagnosis of schizophrenia, 18 or more years old,
clinically stabilized, without axis I DSM-IV comorbidity. Patients
received treatment in the outpatient services of a catchment area
in Madrid. Perceived and anticipated discrimination was evaluated
trough the DISC-12 (Discrimination and Stigma scale). Other study
variables were: socio-demographic characteristics, symptoms of
depression (Calgary Scale) and functionality degree measured by
Global Assessment of Function (GAF).
Results The presence of symptoms of depression evaluated by
the Calgary Scale and low degree of functionality measured by
GAF are associated with greater feelings of discrimination and
stigma, especially in the sub-scales of experienced and antici-
pated discrimination of the DISC 12. Anticipated stigma is higher
in men than in women while the rest sub scales of the DISC-
12 do not correlate with gender or other sociodemographic
variables.
Conclusions Preventive strategies to avoid the stigma in
schizophrenia should consider some characteristics associated
with disease, especially the degree of functionality and presence
of depressive symptoms.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW538
First-episode psychosis: What does it
mean?
S. Marques ∗, F. Godinho , A.L. Melo , D. Barrocas
Hospital do Espírito Santo de Évora, Department of Psychiatry and
Mental Health, Évora, Portugal
∗ Corresponding author.
Introduction First-Episode Psychosis (FEP) is a variable condi-
tion, characterized by the emergence of new psychotic features
for a period of at least 1 week. The majority of existing stud-
ies about FEP only address schizophrenia spectrum psychosis
(SSP), which may limit the capacity to fully characterize this
entity.
Objectives/Aims Report the clinical and socio-demographic char-
acteristics of patients with FEP in real-world setting, and compare
the differences among SSP and affective FEP.